Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jianke operates China’s leading online platform for chronic disease management and retail pharmacy. As of December 31, 2024, it had approximately 49.2 million registered users and about 10.1 million monthly active users. The company provides follow-up physician consultations, e-prescription services by registered physicians (including many from top-tier hospitals), and direct-to-consumer pharmaceutical sales through its robust supply chain. It has expanded into physical hospitals with an emphasis on integrating internet technologies to deliver state-of-the-art care in areas like reproduction, sports rehabilitation, cancer care, and community medicine. The company is profitable with significant revenue growth in recent years.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jianke.